Novel TRKB agonists activate TRKB and downstream ERK and AKT signaling to protect Aβ-GFP SH-SY5Y cells against Aβ toxicity

Decreased BDNF and impaired TRKB signaling contribute to neurodegeneration in Alzheimer’s disease (AD). We have shown previously that coumarin derivative LM-031 enhanced CREB/BDNF/BCL2 pathway. In this study we explored if LM-031 analogs LMDS-1 to -4 may act as TRKB agonists to protect SH-SY5Y cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, Ya-Jen, Lin, Te-Hsien, Chang, Kuo-Hsuan, Lin, Wenwei, Hsieh-Li, Hsiu Mei, Su, Ming-Tsan, Chen, Chiung-Mei, Sun, Ying-Chieh, Lee-Chen, Guey-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550238/
https://www.ncbi.nlm.nih.gov/pubmed/36170028
http://dx.doi.org/10.18632/aging.204306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550238/
https://www.ncbi.nlm.nih.gov/pubmed/36170028
http://dx.doi.org/10.18632/aging.204306

Ejemplares similares